A Comprehensive Guide to Ovarian Cancer

About Ovarian Cancer

Ovarian cancer, predominantly affecting women between the ages of 50 and 65, stands as the second most common reproductive organ cancer in women in the United States. The risk factors encompass early onset of menstruation, late menopause, never having been pregnant, and a family history of specific cancers or genetic conditions. The primary focus here is on the treatment of epithelial ovarian cancer, particularly post-surgery chemotherapy.

Signs and Symptoms

In the initial stages, ovarian cancer may manifest through vague symptoms like pelvic discomfort, bloating, and urinary issues. Sometimes, a mass or lump detected during a routine pelvic examination can be a precursor to a diagnosis of ovarian cancer, although it could also indicate non-cancerous conditions like ovarian cysts.


The diagnosis process usually involves imaging tests such as ultrasound, CT, or MRI, followed by surgery or non-surgical procedures to confirm the presence of cancer cells. The goal is to ascertain the extent and location of the potential cancer.

Conventional Treatments

The primary treatment involves surgery to remove visible cancer and determine its stage. This might include the removal of the uterus, fallopian tubes, and ovaries. Post-surgery, chemotherapy is often recommended to eliminate any remaining cancer cells and reduce the risk of recurrence.

Integrative Medicine for Ovarian Cancer

In addition to conventional treatments, the following integrative therapies can be considered to potentially enhance the effectiveness of the primary treatment plan:

  • Autologous Immunotherapy: Utilizes the patient’s immune cells to target and eliminate cancer cells, potentially enhancing the body’s natural defense mechanisms against ovarian cancer.
  • Pharmacological Immunotherapy: Involves the use of drugs to augment the immune system’s ability to combat ovarian cancer cells, offering a targeted approach to cancer treatment.
  • Dendritic Enhancers: Enhance the function of dendritic cells, which play a pivotal role in immune responses against cancer cells, potentially amplifying the immune response against ovarian cancer.
  • Systemic Perfusion Hyperthermia: A treatment method that employs heat to increase the vulnerability of ovarian cancer cells to other treatments, potentially enhancing the effectiveness of primary therapies.
  • Mistletoe: Utilized as a complementary therapy, mistletoe can help improve symptoms and enhance the quality of life in ovarian cancer patients.
  • Glutathione: A potent antioxidant that helps protect cells from damage, potentially playing a protective role in ovarian cancer treatment.
  • Personalized Nutrition: Tailoring nutrition plans to the individual needs of the patient, supporting overall health and well-being during ovarian cancer treatment.
  • Vitamin D IV: Administered intravenously, it helps in enhancing the immune response and may have protective effects against ovarian cancer.
  • Zinc: An essential mineral that plays a role in immune function and may help in improving the response to ovarian cancer treatment.
  • Melatonin: A hormone that can help in managing sleep disturbances in ovarian cancer patients, enhancing the quality of life.
  • Curcumin: A compound found in turmeric, it has anti-inflammatory and antioxidant properties, potentially offering protective effects against ovarian cancer.
  • Sylimarin: A compound found in milk thistle, it has antioxidant properties and may help in protecting liver function during ovarian cancer treatment.
  • Vitamin E: A potent antioxidant that helps in protecting cells from damage, supporting overall health during ovarian cancer treatment.

By incorporating these integrative treatments, patients with ovarian cancer can potentially benefit from a more holistic approach to cancer care, which may enhance the effectiveness of conventional treatments and improve the quality of life.


The goal of cancer immunotherapy is to improve the body’s natural ability to find and destroy cancer cells. Successful immunotherapeutic approaches stimulate the natural defenses of the immune system and provide new ways to attack cancer. This is possible with comprehensive interventions that include cell therapy / immuno-pharmacological therapy in combination with nutritional, endocrine measures and supplements.

Dendritic enhancer or T-cell modulators

T-cell Modulators are peptide chains composed of tens of amino acids that appear to store all the experience of the immune system. The great intellectual leap to understand is that T-cell Modulators do not transfer antibodies nor create them directly, but its function is to educate, and teach the immune cells to recognize specific antigens that could happen to them unnoticed i.e. Prostate malignant cells.

T-cell Modulators do not cure anything but work to make a “smarter” immune system so that it is the body itself eliminating disease. They are therefore vital in developing the strategies of the immune system against cancer.

T-cell Modulators contains several immunoactivity components that have been shown to act synergistically in raising Dendritic and NK function and also effective as adjuvant therapy, elevating dendritic and NK function as much as 250%.


Hyperthermia involves the use of heat to directly treat a tumor or increase the vulnerability of cancer cells to other forms of treatment, such as immunotherapy, vitamin C, chemotherapy or radiotherapy.

Concerning clinical trials, hyperthermia has already shown antitumor activity and has a potential role in the treatment of ovarian cancer.

Non-ablative or mild hyperthermia (HT) has been shown in preclinical and clinical studies as a localized sensitizer that enhances the tumoricidal effects of immunotherapy, radiation or chemotherapy.

Personalized nutrition

A typical diet, characterized by dependence on animal products, refined carbohydrates and unhealthy fats such as processed vegetable oils, can promote an inflammatory environment in the body.

We custom-make a diet targeted to enhance the immune system’s ability to heal and provide our patients with the right nutrition for their current and long-term needs.

Vitamin D

Vitamin D is a fat-soluble prohormone best known for its role in maintaining calcium homeostasis. Study results indicate that vitamin D deficiency results in an increase in the risk of developing ovarian cancer and that vitamin supplements may potentially be an efficient way of preventing cancer.


Healthy prostate cells accumulate zinc to accomplish their normal cellular functions, Zinc is a potential therapeutic for chemo resistant ovarian cancer, it has been prove that by using zinc in combination with chemotherapy it increases the effectiveness of the systemic treatment.

Diseases Treated at Integrative Immunotherapy Institute

Adrenal Cancer
Anal Cancer
Appendix Cancer
Bile Duct Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Carcinoid Tumors
Cervical Cancer
Colorectal Cancer
Esophageal Cancer
Eye Cancer
Gallbladder Cancer
Gastrointestinal Stromal Tumors (GIST)
Head and Neck Cancer
Hodgkin Lymphoma
Intestinal Cancer

Kidney Cancer
Liver Cancer
Lung Cancer
Metastatic Squamous Neck Cancer
Multiple Myeloma
Non-Hodgkin Lymphoma (NHL)
Oral Cancer
Ovarian Cancer
Pancreatic Cancer
Penile Cancer
Primary Central Nervous System (CNS) Lymphoma
Prostate Cancer
Sinus Cancer
Skin Cancer

Small Intestine Cancer
Soft Tissue Sarcoma
Spinal Cancer
Squamous Cell Carcinoma
Stomach Cancer
Testicular Cancer
Throat Cancer
Thymoma / Thymic Carcinoma
Thyroid Cancer
Urethral Cancer
Uterine Cancer
Vaginal Cancer
Vulvar Cancer

Bacterial & Viral Infections
Hepatitis C
Lyme Disease

Addison’s Disease
Autoimmune Inner Ear Disease (AIED)
Celiac Disease

Crohn’s Disease Treatment in Mexico – Top Clinic
Cushing Syndrome
Graves’ Disease
Guillain-Barre Syndrome

Hemolytic Anemia

Alzheimer’s Disease
Hypertension (High Blood Pressure)
Parkinson’s Disease